Company / Income Tax
MoonLake Immunotherapeutics Income Tax History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$611.0K
FY2025
5-year range
$4.8K / $611.0K
FY2021-FY2025
Trend
+116.7%
vs FY2024
Sector context
#82 of 204
Health Care
What the data says
At $611,000, MoonLake Immunotherapeutics's income tax ranks #123 of 204 in the Health Care sector. Income Tax has increased for 4 consecutive years, from $4,755 in FY2021 to $611,000 in FY2025.
Based on SEC 10-K filings.
$611,000 in FY2025 with a 3-year CAGR of +156.1%.
Increased from $94,000 to $611,000 over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- +156.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#123 of 204 in Health CareTop 60% of 204This company $611.0K Sector average $118.7M
▼
-99.5% below sector average
Key checks
Key Insights
- MoonLake Immunotherapeutics's income tax has grown for 4 consecutive years.
- 3-year CAGR of +156.1%, indicating consistent growth.
- In FY2025, income tax increased 116.7% year-over-year.
- Ranks #82 out of 204 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $611.0K | +116.7% |
| FY2024 | $282.0K | +200.0% |
| FY2023 | $94.0K | +158.5% |
| FY2022 | $36.4K | +664.8% |
| FY2021 | $4.8K | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026